B Wang

925 total citations
11 papers, 768 citations indexed

About

B Wang is a scholar working on Immunology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, B Wang has authored 11 papers receiving a total of 768 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 3 papers in Public Health, Environmental and Occupational Health and 2 papers in Molecular Biology. Recurrent topics in B Wang's work include Immune Cell Function and Interaction (5 papers), T-cell and B-cell Immunology (3 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). B Wang is often cited by papers focused on Immune Cell Function and Interaction (5 papers), T-cell and B-cell Immunology (3 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). B Wang collaborates with scholars based in United States, China and Canada. B Wang's co-authors include Cox Terhorst, Christine A. Biron, Jordan S. Orange, Jingjing She, Mary Jean Sunshine, Nils Lönberg, K M Higgins, Elizabeth Lacy, Jerry Avorn and Aaron S. Kesselheim and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Clinical Pharmacology & Therapeutics.

In The Last Decade

B Wang

11 papers receiving 759 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B Wang United States 9 589 219 91 85 48 11 768
Cheryl Young United States 10 249 0.4× 86 0.4× 79 0.9× 156 1.8× 42 0.9× 12 653
Catherine A. Forbes Australia 17 858 1.5× 453 2.1× 271 3.0× 163 1.9× 50 1.0× 32 1.2k
Stephanie S. Cush United States 10 295 0.5× 170 0.8× 107 1.2× 60 0.7× 50 1.0× 11 518
D. Viza France 16 253 0.4× 174 0.8× 124 1.4× 147 1.7× 95 2.0× 62 694
Maha Al-Mozaini Saudi Arabia 12 152 0.3× 73 0.3× 64 0.7× 84 1.0× 208 4.3× 32 536
Song Jiang United States 9 445 0.8× 126 0.6× 71 0.8× 167 2.0× 43 0.9× 22 721
Richard K. Gyasi Ghana 13 174 0.3× 78 0.4× 106 1.2× 43 0.5× 35 0.7× 39 631
Sara Martina Parigi Italy 11 198 0.3× 65 0.3× 125 1.4× 255 3.0× 49 1.0× 19 602
Giuseppe Privitera Italy 14 196 0.3× 203 0.9× 75 0.8× 243 2.9× 68 1.4× 31 656
Rizwan Ahmed United States 13 159 0.3× 115 0.5× 24 0.3× 141 1.7× 36 0.8× 22 550

Countries citing papers authored by B Wang

Since Specialization
Citations

This map shows the geographic impact of B Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Wang more than expected).

Fields of papers citing papers by B Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Wang. The network helps show where B Wang may publish in the future.

Co-authorship network of co-authors of B Wang

This figure shows the co-authorship network connecting the top 25 collaborators of B Wang. A scholar is included among the top collaborators of B Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B Wang. B Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Wang, Yingying, et al.. (2025). New FDA drug approvals for 2024: Synthesis and clinical application. European Journal of Medicinal Chemistry. 285. 117241–117241. 13 indexed citations
2.
Wang, B, et al.. (2024). Association of dietary inflammatory index with constipation: Evidence from the National Health and Nutrition Examination Survey. Food Science & Nutrition. 12(3). 2122–2130. 5 indexed citations
4.
Wang, B, Jerry Avorn, & Aaron S. Kesselheim. (2013). Clinical and Regulatory Features of Drugs Not Initially Approved by the FDA. Clinical Pharmacology & Therapeutics. 94(6). 670–677. 8 indexed citations
5.
Kesselheim, Aaron S., B Wang, & Jerry Avorn. (2013). Defining “Innovativeness” in Drug Development: A Systematic Review. Clinical Pharmacology & Therapeutics. 94(3). 336–348. 38 indexed citations
6.
Wang, Dan, et al.. (2011). Glutathione S-transferase M1 and T1 polymorphisms and cervical cancer risk: A meta-analysis. Neoplasma. 58(4). 352–359. 18 indexed citations
7.
Guimond, Martin, B Wang, & B. Anne Croy. (1999). Immune Competence Involving the Natural Killer Cell Lineage Promotes Placental Growth. Placenta. 20(5-6). 441–450. 35 indexed citations
8.
9.
Wang, B, et al.. (1996). Natural killer cell development is blocked in the context of aberrant T lymphocyte oxtogeny. International Immunology. 8(6). 939–951. 29 indexed citations
10.
Orange, Jordan S., B Wang, Cox Terhorst, & Christine A. Biron. (1995). Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration.. The Journal of Experimental Medicine. 182(4). 1045–1056. 391 indexed citations
11.
Wang, B, Christine A. Biron, Jingjing She, et al.. (1994). A block in both early T lymphocyte and natural killer cell development in transgenic mice with high-copy numbers of the human CD3E gene.. Proceedings of the National Academy of Sciences. 91(20). 9402–9406. 202 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026